Medicines
General information about medicines, as well as advice on safety information, medicines and pregnancy, and medicine shortages.
More information
- Medicines
- How we regulate medicines
- Medicines and TGA classifications
- Registered medicines
- Australia's medicine labels are becoming clearer
- Tamper-evident packaging
- PI/CMI search facility
- Medicines Repurposing Program - Eligibility criteria and prioritisation considerations
Dispose of unwanted medicines
Health professionals
University student education materials
Latest alerts
-
Extra safety information is being added to all montelukast products to highlight the existing warnings about serious behaviour and mood-related changes.
-
The supply of Ozempic (semaglutide) will continue to be limited until 31 December 2025
-
Pharmacists can use a Serious Scarcity Substitution Instrument (SSSI) to dispense Protaphane Penfill human insulin in the place of a Protaphane InnoLet cartridge.
Latest articles
-
More prominent safety warnings about the neuropsychiatric effects of montelukast
Additional safety information is being added to all montelukast products to strengthen and highlight existing warnings about serious neuropsychiatric events. -
Consent relating to listed medicines that contain whole live microorganisms as an active ingredient
This consent is given under sections 14 and 14A of the Therapeutic Goods Act 1989. -
Recall reforms update and new procedure
Recall reforms program update and preview of the PRAC Version 1.0.
Latest publications
-
Publication of the decisions made by a delegate of the Secretary in relation to to nicotinic acid.
-
Advisory Committee on Complementary Medicines meeting statement for 14 March 2024
-
This web publication constitutes a notice for the purposes of regulations 42ZCZS and 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations).
Latest consultations
-
Have your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Chemicals Scheduling (ACCS) and joint meeting of the Advisory Committee on Medicines Scheduling (ACMS) and ACCS.
-
We are seeking feedback on whether 19 international scientific guidelines should be adopted.
-
We are seeking feedback on proposed improvements to TGA’s regulatory framework for medicine shortages and discontinuations in Australia.